BioVaxys Technology Market Cap

BioVaxys Technology has a market cap or net worth of CAD 2.65 million as of April 28, 2026. Its market cap has decreased by -83.50% in one year.

Market Cap

2.65M

Enterprise Value

2.78M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.06

Market Cap Chart

Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 2.65M, a decrease of -90.22%. That is a compound annual growth rate of -34.18%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	3.09M	-68.18%
Dec 31, 2025	9.70M	-41.13%
Dec 31, 2024	16.48M	127.10%
Dec 29, 2023	7.26M	-47.89%
Dec 30, 2022	13.92M	-26.37%
Dec 31, 2021	18.91M	32.10%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Appili Therapeutics	2.65M
Rakovina Therapeutics	2.33M
ASEP Medical Holdings	3.45M
Cytophage Technologies	4.40M
Universal Ibogaine	1.56M
Restart Life Sciences	4.75M
Doseology Sciences	4.97M
Entheon Biomedical	1.39M

Market Cap Rankings